Dermatological Drug Delivery refers to the science and technology of administering medications and therapeutic agents to the skin for the treatment of various dermatological conditions. It encompasses a wide range of delivery systems and strategies designed to optimize drug absorption, distribution, and efficacy while minimizing side effects and improving patient compliance. Topical formulations are the most common method of dermatological drug delivery, including creams, ointments, gels, lotions, foams, and sprays. These formulations allow drugs to penetrate the skin barrier and exert their effects locally, targeting specific skin conditions such as acne, eczema, psoriasis, and fungal infections. Transdermal drug delivery systems deliver medications through the skin and into the bloodstream, providing systemic effects. Transdermal patches, for example, deliver drugs continuously over an extended period, offering advantages such as convenience, steady drug levels, and reduced gastrointestinal side effects. Nanotechnology has revolutionized dermatological drug delivery, enabling the development of nanoparticles, liposomes, and other nanocarriers that enhance drug stability, solubility, and penetration into the skin. These nanocarriers can encapsulate drugs, protect them from degradation, and facilitate targeted delivery to specific skin layers or cells. Microneedle technology involves the use of microscopic needles to create pathways through the skin, allowing drugs to penetrate more deeply and efficiently. This approach is particularly useful for delivering large molecules, such as peptides and proteins, which may have limited skin penetration on their own. Innovations in dermatological drug delivery continue to improve treatment outcomes and patient satisfaction by enhancing drug bioavailability, minimizing side effects, and optimizing convenience and compliance. Research in this field focuses on developing novel delivery systems, improving drug stability and targeting, and exploring personalized approaches to dermatologic therapy.
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : The new physiopathology of cellulite
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : A twelve week clinical study testing efficacy and safety of a cosmetic cream with novel actives for uneven skin tone, hyperpigmentation & photoaging
Nalini Kaul, Princeton Consumer Research, Canada
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Bioregeneration in aesthetic and functional gynecology
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : The management of FPHL- How it different from male AGA
Rachita Dhurat, LTMMC & LTMG Hospital, India
Title : Tackling stubborn wound by advanced polysaccharides-based biopolymer delivery system
Madhu Gupta, Delhi Pharmaceutical Science and Research University, India